All In Biotech

Drug Trial Radar · NCT01199289

A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Determine the Safety and Efficacy of AMG 827 in Subjects With Inadequately Controlled Asthma

Last checked: Nov 20, 2026Latest source record: Nov 26, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 315 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

315

Actual

Start

Oct 4, 2010

Primary completion

Dec 21, 2011

Study completion Dec 21, 2011

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Sep 10, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if AMG 827 is effective compared to placebo as measured by change in Asthma Control Questionnaire (ACQ) composite scores.

Conditions

  • Asthma

Interventions

  • AMG 827Drug

    SC injection.

  • PlaceboDrug

    SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Asthma Control Questionnaire (ACQ) Composite Scores to Week 12Time frame: Baseline and Week 12

Locations

49 sites in 10 countries. Site status is shown where the registry gives one.

  • Research Site

    Encinitas, California

  • Research Site

    Huntington Beach, California

  • Research Site

    Los Angeles, California

  • Research Site

    San Diego, California

  • Research Site

    Stockton, California

  • Research Site

    Colorado Springs, Colorado

  • Research Site

    Stockbridge, Georgia

  • Research Site

    Baltimore, Maryland

  • Research Site

    North Dartmouth, Massachusetts

  • Research Site

    St Louis, Missouri

  • Research Site

    Bozeman, Montana

  • Research Site

    Bellevue, Nebraska

  • Research Site

    Skillman, New Jersey

  • Research Site

    Rockville Centre, New York

  • Research Site

    High Point, North Carolina

  • Research Site

    Cincinnati, Ohio

  • Research Site

    Lake Oswego, Oregon

  • Research Site

    Medford, Oregon

  • Research Site

    Pittsburgh, Pennsylvania

  • Research Site

    Dallas, Texas

  • Research Site

    El Paso, Texas

  • Research Site

    Madison, Wisconsin

  • Research Site

    Feldbach, Austria

  • Research Site

    Hallein, Austria

  • Research Site

    Vienna, Austria

  • Research Site

    Brussels, Belgium

  • Research Site

    Leuven, Belgium

  • Research Site

    Liège, Belgium

  • Research Site

    Calgary, Alberta, Canada

  • Research Site

    Ottawa, Ontario, Canada

  • Research Site

    Toronto, Ontario, Canada

  • Research Site

    Helsinki, Finland

  • Research Site

    Jyväskylä, Finland

  • Research Site

    Turku, Finland

  • Research Site

    Edelény, Hungary

  • Research Site

    Mátraháza, Hungary

  • Research Site

    Tatabánya, Hungary

  • Research Site

    Törökbálint, Hungary

  • Research Site

    Zalaegerszeg - Pozva, Hungary

  • Research Site

    Rotterdam, Netherlands

Showing 40 of 49 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.